| scholarly article | Q13442814 |
| P50 | author | Kaitlin Kentala | Q87616276 |
| Jared C Lewis | Q87826882 | ||
| P2093 | author name string | Michael W Beck | |
| Bryan C Dickinson | |||
| Weiwei An | |||
| Alexander R Lippert | |||
| Krysten A Jones | |||
| P2860 | cites work | Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions | Q24532168 |
| Bimolecular fluorescence complementation (BiFC): a 5-year update and future perspectives | Q27009598 | ||
| Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP | Q27732817 | ||
| Principles of protein-protein interactions | Q27860855 | ||
| Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation | Q28244717 | ||
| A split horseradish peroxidase for the detection of intercellular protein-protein interactions and sensitive visualization of synapses | Q28276002 | ||
| Reaching for high-hanging fruit in drug discovery at protein-protein interfaces | Q29547258 | ||
| The synaptic vesicle cycle: a cascade of protein-protein interactions | Q29620168 | ||
| In vivo and in vitro protein solubility assays using split GFP. | Q30824549 | ||
| Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. | Q31856730 | ||
| Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions | Q32123133 | ||
| Bright building blocks for chemical biology | Q33551601 | ||
| Opening a Gateway for Chemiluminescence Cell Imaging: Distinctive Methodology for Design of Bright Chemiluminescent Dioxetane Probes. | Q33612449 | ||
| A synthetic luciferin improves bioluminescence imaging in live mice | Q33631918 | ||
| Design and synthesis of a beta-lactamase activated 5-fluorouracil prodrug. | Q33726983 | ||
| Split-protein systems: beyond binary protein-protein interactions | Q34070966 | ||
| Modular extracellular sensor architecture for engineering mammalian cell-based devices | Q34167797 | ||
| Selective esterase-ester pair for targeting small molecules with cellular specificity | Q34192621 | ||
| Small-molecule inhibitors of protein-protein interactions: progressing toward the reality | Q34263719 | ||
| Visualization of molecular interactions using bimolecular fluorescence complementation analysis: characteristics of protein fragment complementation | Q34305981 | ||
| Kinetics-Based Measurement of Hypoxia in Living Cells and Animals Using an Acetoxymethyl Ester Chemiluminescent Probe | Q90010746 | ||
| Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study) | Q90291999 | ||
| Rational Design and Facile Synthesis of a Highly Tunable Quinoline-Based Fluorescent Small-Molecule Scaffold for Live Cell Imaging | Q90360647 | ||
| Design of fast proteolysis-based signaling and logic circuits in mammalian cells | Q90371724 | ||
| Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma | Q90858653 | ||
| Evolution of C-Terminal Modification Tolerance in Full-Length and Split T7 RNA Polymerase Biosensors | Q91265775 | ||
| Recent Advances and Challenges in Luminescent Imaging: Bright Outlook for Chemiluminescence of Dioxetanes in Water | Q91535198 | ||
| A split-Cas9 architecture for inducible genome editing and transcription modulation | Q34460920 | ||
| Engineering the ABA plant stress pathway for regulation of induced proximity | Q35031343 | ||
| Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist | Q35610650 | ||
| Cell-free synthetic biology: thinking outside the cell | Q35878115 | ||
| Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines | Q35902206 | ||
| New methodologies for measuring protein interactions in vivo and in vitro | Q36046401 | ||
| Cell type-specific pharmacology of NMDA receptors using masked MK801. | Q36124201 | ||
| Visualizing cellular interactions with a generalized proximity reporter | Q36884190 | ||
| A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging. | Q37015065 | ||
| Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma | Q37718554 | ||
| Interactome mapping for analysis of complex phenotypes: insights from benchmarking binary interaction assays | Q38010411 | ||
| Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. | Q38172752 | ||
| Split-luciferase complementary assay: applications, recent developments, and future perspectives | Q38227133 | ||
| Mapping biochemical networks with protein fragment complementation assays | Q38414226 | ||
| ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development | Q38640917 | ||
| Tumour-selective targeting of drug metabolizing enzymes to treat metastatic cancer | Q38898663 | ||
| A new non-disruptive strategy to target calcium indicator dyes to the endoplasmic reticulum | Q39881694 | ||
| Development of pyrrolo[2,1-c][1,4]benzodiazepine beta-galactoside prodrugs for selective therapy of cancer by ADEPT and PMT. | Q40016903 | ||
| Antitumor activity of edotecarin in breast carcinoma models | Q40211112 | ||
| NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells | Q40319794 | ||
| Nitroarylmethylcarbamate prodrugs of doxorubicin for use with nitroreductase gene-directed enzyme prodrug therapy | Q40418398 | ||
| Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy | Q40612485 | ||
| Unlocking the Potential of Chemiluminescence Imaging | Q42357520 | ||
| Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase | Q43657345 | ||
| Ester bonds in prodrugs | Q44937687 | ||
| A general method to fine-tune fluorophores for live-cell and in vivo imaging | Q45066487 | ||
| Fluorogenic Targeting of Voltage-Sensitive Dyes to Neurons. | Q46400196 | ||
| Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism | Q46678390 | ||
| Synthesis and Evaluation as Prodrugs of Hydrophilic Carbamate Ester Analogues of Resveratrol | Q46687732 | ||
| Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab | Q47613628 | ||
| RNA Polymerase Tags To Monitor Multidimensional Protein-Protein Interactions Reveal Pharmacological Engagement of Bcl-2 Proteins. | Q47853163 | ||
| Multidimensional Control of Cas9 by Evolved RNA Polymerase-Based Biosensors. | Q47951224 | ||
| Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer | Q50109053 | ||
| A "Caged" Luciferin for Imaging Cell-Cell Contacts. | Q50961156 | ||
| Evolution of a split RNA polymerase as a versatile biosensor platform. | Q51006974 | ||
| Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients. | Q52658441 | ||
| A versatile esterase from Bacillus subtilis: cloning, expression, characterization, and its application in biocatalysis. | Q54451222 | ||
| Continuous directed evolution of proteins with improved soluble expression | Q56873918 | ||
| Cell-Specific Chemical Delivery Using a Selective Nitroreductase–Nitroaryl Pair | Q59918601 | ||
| Luciferase-LOV BRET enables versatile and specific transcriptional readout of cellular protein-protein interactions | Q64079530 | ||
| Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area. | Q64892301 | ||
| Novel anthracycline-spacer-beta-glucuronide,-beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy | Q78246228 | ||
| Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402 | Q83339502 | ||
| P433 | issue | 11 | |
| P921 | main subject | protein-protein interaction | Q896177 |
| P304 | page(s) | 1768-1776 | |
| P577 | publication date | 2019-09-24 | |
| P1433 | published in | ACS Central Science | Q27726586 |
| P1476 | title | Development of a Split Esterase for Protein-Protein Interaction-Dependent Small-Molecule Activation | |
| P478 | volume | 5 |
| Q91742508 | A Novel Split Reporter Uncages New Possibilities | cites work | P2860 |
Search more.